三维染色体景观揭示狼疮中miR-146a功能失调增强子并建立CRISPR介导的抑制干扰素通路方法
研究应用环形染色体构象捕获测序和表观基因组图谱鉴定miR-146a的候选增强子,通过CRISPR激活筛选功能性增强子,发现miR-146a下游32.5 kb增强子在SLE中染色质开放性降低且与疾病活动度负相关,CRISPR激活该增强子可抑制SLE患者PBMCs的干扰素通路活性。
要点
- 鉴定出miR-146a在免疫细胞中的共享及细胞特异性增强子。
- miR-146a下游32.5 kb增强子在SLE中开放性降低且与疾病活动度负相关。
- CRISPR激活该增强子可抑制SLE患者PBMCs的干扰素通路活性。
核心结论
- 研究定义了SLE干预的一个有前景的靶点,采用整合方法确定了SLE关键基因的细胞特异性和功能性增强子,并阐明了狼疮相关增强子介导其失调的机制。
研究设计与样本
- 应用环形染色体构象捕获测序和表观基因组图谱鉴定miR-146a候选增强子,通过CRISPR激活筛选功能性增强子,分析染色质可及性差异识别SLE失调增强子,并通过转录因子结合分析研究增强子功能障碍机制,最后在SLE患者外周血单个核细胞中通过CRISPR激活靶向狼疮相关增强子评估治疗价值。
主要发现
- 在 distinct 免疫细胞中鉴定出miR-146a的共享和细胞特异性增强子。
- miR-146a下游32.5 kb的增强子在SLE中可及性较低,其染色质开放程度与SLE疾病活动度呈负相关。
- CCAAT/增强子结合蛋白α在SLE患者中表达下调,其结合至32.5-kb增强子并诱导该位点的表观基因组改变。
- 在SLE患者PBMCs中基于CRISPR激活该增强子可抑制干扰素通路活性。
关键数值与推荐
- miR-146a下游32.5 kb增强子在SLE中可及性较低,其染色质开放程度与SLE疾病活动度呈负相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The diminished expression of microRNA-146a (miR-146a) in systemic lupus erythematosus (SLE) contributes to the aberrant activation of the interferon pathway. Despite its significance, the underlying mechanism driving this reduced expression remains elusive. Considering the integral role of enhancers in steering gene expression, our study seeks to pinpoint the SLE-affected enhancers responsible for modulating miR-146a expression. Additionally, we aim to elucidate the mechanisms by which these enhancers influence the contribution of miR-146a to the activation of the interferon pathway. METHODS: Circular chromosome conformation capture sequencing and epigenomic profiles were applied to identify candidate enhancers of miR-146a. CRISPR activation was performed to screen functional enhancers. Differential analysis of chromatin accessibility was used to identify SLE-dysregulated enhancers, and the mechanism underlying enhancer dysfunction was investigated by analyzing transcription factor binding. The therapeutic value of a lupus-related enhancer was further evaluated by targeting it in the peripheral blood mononuclear cells (PBMCs) of patients with SLE through a CRISPR activation approach. RESULTS: We identified shared and cell-specific enhancers of miR-146a in distinct immune cells. An enhancer 32.5 kb downstream of miR-146a possesses less accessibility in SLE, and its chromatin openness was negatively correlated with SLE disease activity. Moreover, CCAAT/enhancer binding protein α, a down-regulated transcription factor in patients with SLE, binds to the 32.5-kb enhancer and induces the epigenomic change of this locus. Furthermore, CRISPR-based activation of this enhancer in SLE PBMCs could inhibit the activity of interferon pathway. CONCLUSION: Our work defines a promising target for SLE intervention. We adopted integrative approaches to define cell-specific and functional enhancers of the SLE critical gene and investigated the mechanism underlying its dysregulation mediated by a lupus-related enhancer.
引用
- Zhu X, Zhang Y, Yin Z, et al. Three-Dimensional Chromosomal Landscape Revealing miR-146a Dysfunctional Enhancer in Lupus and Establishing a CRISPR-Mediated Approach to Inhibit the Interferon Pathway. Arthritis Rheumatol. 2023. PMID: 37728419. doi:10.1002/art.42703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。